Dr. Richard Stone talks about a patient who benefited from Profile, Dana-Farber's precision medicine program. Dr. Barrett Rollins and Dr. Matthew Meyerson also comment.
Dr. Laurie H. Glimcher is picked as next Chief Executive Officer of Dana-Farber Cancer Institute.
Tags: CervicalCancer, PatientEducation, GynecologicCancers
Tags: ChildhoodCancer, Genomics, Genetics
Tags: PatientEducation, TargetedTherapy, Genetics
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: